» Articles » PMID: 27885749

Biophysical Modeling to Determine the Optimization of Left Ventricular Pacing Site and AV/VV Delays in the Acute and Chronic Phase of Cardiac Resynchronization Therapy

Abstract

Background: Cardiac anatomy and function adapt in response to chronic cardiac resynchronization therapy (CRT). The effects of these changes on the optimal left ventricle (LV) lead location and timing delay settings have yet to be fully explored.

Objective: To predict the effects of chronic CRT on the optimal LV lead location and device timing settings over time.

Methods: Biophysical computational cardiac models were generated for 3 patients, immediately post-implant (ACUTE) and after at least 6 months of CRT (CHRONIC). Optimal LV pacing area and device settings were predicted by pacing the ACUTE and CHRONIC models across the LV epicardium (49 sites each) with a range of 9 pacing settings and simulating the acute hemodynamic response (AHR) of the heart.

Results: There were statistically significant differences between the distribution of the AHR in the ACUTE and CHRONIC models (P < 0.0005 in all cases). The site delivering the maximal AHR shifted location between the ACUTE and CHRONIC models but provided a negligible improvement (<2%). The majority of the acute optimal LV pacing regions (76-100%) and device settings (76-91%) remained optimal chronically.

Conclusion: Optimization of the LV pacing location and device settings were important at the time of implant, with a reduced benefit over time, where the majority of the acute optimal LV pacing region and device settings remained optimal with chronic CRT.

Citing Articles

Personalized computational electro-mechanics simulations to optimize cardiac resynchronization therapy.

Capuano E, Regazzoni F, Maines M, Fornara S, Locatelli V, Catanzariti D Biomech Model Mechanobiol. 2024; 23(6):1977-2004.

PMID: 39192164 PMC: 11554892. DOI: 10.1007/s10237-024-01878-8.


Cardiac Resynchronization Therapy for Adult Patients With a Failing Systemic Right Ventricle: A Multicenter Study.

Kharbanda R, Moore J, Lloyd M, Galotti R, Bogers A, Taverne Y J Am Heart Assoc. 2022; 11(22):e025121.

PMID: 36346046 PMC: 9750073. DOI: 10.1161/JAHA.121.025121.


Heart-on-Chip for Combined Cellular Dynamics Measurements and Computational Modeling Towards Clinical Applications.

Park J, Wu Z, Steiner P, Zhu B, Zhang J Ann Biomed Eng. 2022; 50(2):111-137.

PMID: 35039976 DOI: 10.1007/s10439-022-02902-7.


Optimization of cardiac resynchronization therapy based on a cardiac electromechanics-perfusion computational model.

Fan L, Choy J, Raissi F, Kassab G, Lee L Comput Biol Med. 2021; 141:105050.

PMID: 34823858 PMC: 8810745. DOI: 10.1016/j.compbiomed.2021.105050.


Parameter variations in personalized electrophysiological models of human heart ventricles.

Ushenin K, Kalinin V, Gitinova S, Sopov O, Solovyova O PLoS One. 2021; 16(4):e0249062.

PMID: 33909606 PMC: 8081243. DOI: 10.1371/journal.pone.0249062.


References
1.
Chung E, Leon A, Tavazzi L, Sun J, Nihoyannopoulos P, Merlino J . Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008; 117(20):2608-16. DOI: 10.1161/CIRCULATIONAHA.107.743120. View

2.
Niederer S, Plank G, Chinchapatnam P, Ginks M, Lamata P, Rhode K . Length-dependent tension in the failing heart and the efficacy of cardiac resynchronization therapy. Cardiovasc Res. 2010; 89(2):336-43. DOI: 10.1093/cvr/cvq318. View

3.
Singh J, Klein H, Huang D, Reek S, Kuniss M, Quesada A . Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation. 2011; 123(11):1159-66. DOI: 10.1161/CIRCULATIONAHA.110.000646. View

4.
Niederer S, Mitchell L, Smith N, Plank G . Simulating human cardiac electrophysiology on clinical time-scales. Front Physiol. 2011; 2:14. PMC: 3079856. DOI: 10.3389/fphys.2011.00014. View

5.
Rinaldi C, Kranig W, Leclercq C, Kacet S, Betts T, Bordachar P . Acute effects of multisite left ventricular pacing on mechanical dyssynchrony in patients receiving cardiac resynchronization therapy. J Card Fail. 2013; 19(11):731-8. DOI: 10.1016/j.cardfail.2013.10.003. View